Pharmaceuticals
Cable admits Pfizer-AstaraZeneca deal involves ‘national interest’ issues
05 May 2014
Britain’s Business Secretary Vince Cable said late on Sunday that the bid by Pfizer Inc for AstraZeneca Plc raised questions of “overriding national interest”, as the opposition Labour Party stepped up its campaign against the proposed takeover
AstraZeneca rejects Pfizer’s revised $106 billion offer
02 May 2014
Today’s 50 pounds ($84.47) a share indicative offer followed AstraZeneca's decision to reject an earlier proposal that valued it at 46.61 pounds per share
AstraZeneca to consider Pfizer’s $106-bn bid
02 May 2014
The announcement comes just days after AstraZeneca Plc denied plans to discuss any partnership proposals with Pfizer
Bayer offers to swap cash and animal health unit for Merck's consumer healthcare
30 Apr 2014
German healthcare major Bayer AG has offered to swap its animal health unit and also pay some cash in exchange for Merck & Co's consumer healthcare business
HC blocks Ranbaxy-Sun Pharma merger over insider trading allegations
30 Apr 2014
The order was in response to a petition for a Sebi inquiry into possible insider trading in Ranbaxy shares that saw heavy trading before the merger with Sun Pharma was announced
Reckitt Benckiser confirms bidding for Merck & Co's consumer health business
29 Apr 2014
British consumer goods company Reckitt Benckiser has emerged as a front runner in the auction, although Bayer AG, Novartis, and Procter & Gamble Co are also in the race
Pfizer confirms AstraZeneca's rejection; to explore options
28 Apr 2014
US drugs giant Pfizer today confirmed that it had made a $98.67 billion (£58.73 billion) takeover offer for AstraZeneca, which was rejected by the UK-based company
.webp)
.webp)
